JSM2023
Back to all people

Keaven Anderson

Merck & Co., Inc.
1 appearance in the program

Sessions & presentations

Advancing medical research with innovative methods for time-to-event outcomes
Presentation: Maximizing probability of success for Phase 3 oncology trials
Invited Paper Session · Wed, Aug 9 , 10:30 AM
Speaker
↑